CO5700832A2 - Suspensiones acuosas de ciclesonide para nebulizacion - Google Patents
Suspensiones acuosas de ciclesonide para nebulizacionInfo
- Publication number
- CO5700832A2 CO5700832A2 CO06054801A CO06054801A CO5700832A2 CO 5700832 A2 CO5700832 A2 CO 5700832A2 CO 06054801 A CO06054801 A CO 06054801A CO 06054801 A CO06054801 A CO 06054801A CO 5700832 A2 CO5700832 A2 CO 5700832A2
- Authority
- CO
- Colombia
- Prior art keywords
- ciclesonide
- nebulization
- suspensions
- waterproof
- aqueous suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Método para preparar una suspensión acuosa estéril de ciclesonide, adecuada para nebulización, caracterizado porque comprende los pasos de:(a). proveer una suspensión acuosa de ciclesonide, que contiene uno o más excipientes aceptables para uso farmacéutico, con uno o más excipientes, todos los cuales son excipientes no iónicos; y (b). tratar en autoclave la suspensión acuosa provista en (a).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03028848 | 2003-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5700832A2 true CO5700832A2 (es) | 2006-11-30 |
Family
ID=34684543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO06054801A CO5700832A2 (es) | 2003-12-16 | 2006-06-07 | Suspensiones acuosas de ciclesonide para nebulizacion |
Country Status (22)
Country | Link |
---|---|
US (2) | US20070117783A1 (es) |
EP (2) | EP2319858B1 (es) |
JP (1) | JP5001657B2 (es) |
KR (1) | KR101086095B1 (es) |
CN (1) | CN100513417C (es) |
AR (1) | AR046892A1 (es) |
AU (1) | AU2004298447B2 (es) |
BR (1) | BRPI0416854B8 (es) |
CA (1) | CA2549038C (es) |
CO (1) | CO5700832A2 (es) |
EA (1) | EA012388B1 (es) |
EC (1) | ECSP066608A (es) |
HK (1) | HK1098486A1 (es) |
IL (1) | IL175461A (es) |
MY (1) | MY159377A (es) |
NO (1) | NO337225B1 (es) |
NZ (1) | NZ547217A (es) |
PE (1) | PE20050941A1 (es) |
TW (1) | TWI350757B (es) |
UA (1) | UA87123C2 (es) |
WO (1) | WO2005058935A2 (es) |
ZA (1) | ZA200603768B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2022796A1 (en) * | 2007-08-07 | 2009-02-11 | Nycomed GmbH | Amorphous ciclesonide |
US7984792B2 (en) * | 2008-03-03 | 2011-07-26 | Rolls-Royce Corporation | Lubrication system |
CA2745411A1 (en) * | 2008-12-03 | 2010-06-10 | Ltt Bio-Pharma Co., Ltd. | Inhalant containing modified superoxide dismutase |
CA3004707C (en) | 2009-09-02 | 2022-05-31 | Synedgen Inc. | Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds |
AU2012212269B2 (en) * | 2011-01-31 | 2016-05-19 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
RU2014109079A (ru) | 2011-08-12 | 2015-09-20 | Бёрингер Ингельхайм Ветмедика Гмбх | Фармацевтическая композиция с маскированным вкусом |
MX2014001940A (es) | 2011-08-18 | 2014-03-27 | Takeda Gmbh | Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal. |
CN103917223B (zh) | 2011-09-14 | 2017-08-08 | 盐野义制药株式会社 | 供吸入的药用组合物 |
ES2706757T3 (es) | 2012-12-21 | 2019-04-01 | Boehringer Ingelheim Vetmedica Gmbh | Formulación farmacéutica que comprende ciclesonida |
LT2934479T (lt) | 2012-12-21 | 2018-12-27 | Boehringer Ingelheim Vetmedica Gmbh | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui |
NZ722927A (en) | 2014-01-10 | 2022-07-29 | Avalyn Pharma Inc | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
RS59613B1 (sr) | 2014-06-18 | 2020-01-31 | Boehringer Ingelheim Vetmedica Gmbh | Muskarinski antagonisti i njihove kombinacije za lečenje bolesti disajnih puteva kod konja |
KR20170094121A (ko) * | 2014-09-11 | 2017-08-17 | 시너드젠, 인크. | 조성물 및 그의 사용 방법 |
WO2017022814A1 (ja) * | 2015-08-05 | 2017-02-09 | 第一三共株式会社 | ネブライザー用組成物 |
CN106692163A (zh) * | 2015-11-13 | 2017-05-24 | 天津金耀集团有限公司 | 一种吸入用环索奈德混悬液组合物 |
WO2019090405A1 (pt) * | 2017-11-11 | 2019-05-16 | Carvalho Junior Mario Virgilio De | Medicamento de ciclesonida para cura e prevenção da gripe causada pelo vírus influenza |
US20210346613A1 (en) * | 2020-05-05 | 2021-11-11 | Mahesh Kumar KHAITAN | Controlled delivery device for treating coronavirus infections and methods thereof |
CN115835885A (zh) * | 2020-06-23 | 2023-03-21 | 广州谷森制药有限公司 | 包含奥达特罗和布***的药物组合物的制备 |
WO2022213101A1 (en) * | 2021-04-01 | 2022-10-06 | Vitrean Inc. | Methods for manufacturing of highly concentrated hydrogels |
WO2022231533A1 (en) * | 2021-04-29 | 2022-11-03 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of sterilized suspensions for the inhalation by nebulization |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE458986B (sv) * | 1985-03-29 | 1989-05-29 | Draco Ab | Dosfoerpackning |
SE8600632D0 (sv) * | 1986-02-13 | 1986-02-13 | Kabivitrum Ab | Novel pharmaceutical composition |
GR1001529B (el) | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
NZ265054A (en) * | 1993-04-02 | 1997-08-22 | Byk Gulden Lomberg Chem Fab | 16-hydroxy prednisolone cyclohexanecarboxaldehyde acetal derivatives |
US5540930A (en) * | 1993-10-25 | 1996-07-30 | Pharmos Corporation | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
GB9410222D0 (en) | 1994-05-21 | 1994-07-06 | Glaxo Wellcome Australia Ltd | Medicaments |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
DE19541689A1 (de) | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
DE19635498A1 (de) | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Verfahren zur Epimerenanreicherung |
US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
CN1245955C (zh) | 1998-05-29 | 2006-03-22 | 斯凯伊药品加拿大公司 | 热保护微粒组合物及其最终蒸汽灭菌的方法 |
US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
IT1303692B1 (it) | 1998-11-03 | 2001-02-23 | Chiesi Farma Spa | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
IT1313553B1 (it) * | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
WO2001028517A1 (fr) | 1999-10-20 | 2001-04-26 | Teijin Limited | Compositions therapeutiques aqueuses |
AR026072A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
EP1337279B1 (en) * | 2000-11-24 | 2006-06-21 | Breath Limited | Sterilisation of glucocorticosteriode suspensions |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
DE10145361A1 (de) * | 2001-09-14 | 2003-04-03 | Pari Gmbh | Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation |
WO2003035030A1 (en) | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
DK1476201T3 (da) | 2002-02-19 | 2009-03-30 | Resolution Chemicals Ltd | Solvent-baseret sterilisering af steroider |
NZ535275A (en) | 2002-03-04 | 2007-03-30 | Nymox Corp | Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom |
WO2003086437A1 (fr) | 2002-04-12 | 2003-10-23 | Ajinomoto Co., Inc. | Composition destinee a prevenir l'arteriosclerose |
ITMI20020808A1 (it) | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
NZ537945A (en) * | 2002-07-02 | 2007-08-31 | Altana Pharma Ag | Ciclesonide-containing sterile aqueous suspension |
JP4364486B2 (ja) | 2002-07-02 | 2009-11-18 | 帝人株式会社 | 無菌水性懸濁製剤 |
US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
KR101067795B1 (ko) * | 2002-08-30 | 2011-09-27 | 니코메드 게엠베하 | 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도 |
JP3857708B2 (ja) | 2002-09-24 | 2006-12-13 | 富士通株式会社 | 歪み波形制御装置、歪み規制部材、歪み波形制御装置の歪み波形制御方法、及び歪み波形制御プログラム |
CA2500908A1 (en) | 2002-10-04 | 2004-04-22 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
ITMI20022674A1 (it) * | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
EP1454636A1 (en) | 2003-03-04 | 2004-09-08 | Dompé S.P.A. | Sterilization of glucocorticoid drug particles for pulmonary delivery |
MY143936A (en) | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US8371292B2 (en) * | 2003-09-16 | 2013-02-12 | Nycomed Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
DE602005026225D1 (de) | 2004-03-12 | 2011-03-24 | Cipla Ltd | Sterilisationsprozess für Steroide |
GB0410995D0 (en) | 2004-05-17 | 2004-06-23 | Norton Healthcare Ltd | Heat sterilization of glucocorticosteroids |
ITSA20040012A1 (it) | 2004-09-07 | 2004-12-07 | Genetec S P A | Processo di sterilizzazione di un glucocorticosteroide. |
GB0425266D0 (en) | 2004-11-16 | 2004-12-15 | Norton Healthcare Ltd | Pharmaceutical manufacturing process |
-
2004
- 2004-12-10 PE PE2004001247A patent/PE20050941A1/es active IP Right Grant
- 2004-12-14 MY MYPI20045134A patent/MY159377A/en unknown
- 2004-12-15 US US10/582,499 patent/US20070117783A1/en not_active Abandoned
- 2004-12-15 EP EP10173237.8A patent/EP2319858B1/en active Active
- 2004-12-15 WO PCT/EP2004/053495 patent/WO2005058935A2/en active Application Filing
- 2004-12-15 EA EA200601091A patent/EA012388B1/ru not_active IP Right Cessation
- 2004-12-15 AR ARP040104661A patent/AR046892A1/es not_active Application Discontinuation
- 2004-12-15 KR KR1020067013760A patent/KR101086095B1/ko active IP Right Grant
- 2004-12-15 CN CNB2004800368287A patent/CN100513417C/zh active Active
- 2004-12-15 JP JP2006544438A patent/JP5001657B2/ja active Active
- 2004-12-15 NZ NZ547217A patent/NZ547217A/en unknown
- 2004-12-15 CA CA2549038A patent/CA2549038C/en not_active Expired - Fee Related
- 2004-12-15 BR BRPI0416854A patent/BRPI0416854B8/pt active IP Right Grant
- 2004-12-15 AU AU2004298447A patent/AU2004298447B2/en active Active
- 2004-12-15 EP EP04804847A patent/EP1697398B1/en active Active
- 2004-12-15 UA UAA200607589A patent/UA87123C2/uk unknown
- 2004-12-16 TW TW093139206A patent/TWI350757B/zh active
-
2006
- 2006-05-07 IL IL175461A patent/IL175461A/en active IP Right Grant
- 2006-05-11 ZA ZA200603768A patent/ZA200603768B/en unknown
- 2006-06-05 EC EC2006006608A patent/ECSP066608A/es unknown
- 2006-06-07 CO CO06054801A patent/CO5700832A2/es active IP Right Grant
- 2006-06-30 NO NO20063047A patent/NO337225B1/no unknown
-
2007
- 2007-05-02 HK HK07104659.7A patent/HK1098486A1/xx unknown
-
2015
- 2015-09-25 US US14/865,637 patent/US11052042B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5700832A2 (es) | Suspensiones acuosas de ciclesonide para nebulizacion | |
UY27940A1 (es) | Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a | |
CR7583A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
ATE520007T1 (de) | Bildgebungsgeometrie | |
UY28001A1 (es) | Derivados de azol-pirimidina condensados | |
ITPD20000208A0 (it) | Polisaccaridi percarbossilati, processo per la loro preparazione e loro impiego in campo farmaceutico e biomedico-sanitario. | |
CY1110878T1 (el) | Διαδικασιες για την μετρηση της ισχυος του glatiramer acetate | |
CO4560552A1 (es) | Antagonistas de receptores de taquicininas no peptidicos | |
BR0116991B1 (pt) | sistema de diagnóstico e terapêutico para cirurgia a laser de olho. | |
UY28348A1 (es) | Compuestos novedosos | |
BRPI0519298A2 (pt) | mÉtodo de preparaÇço de um tecido biolàgico fixado | |
BRPI0212137A2 (pt) | diidropteridinonas, processos para prepará-las e seu uso como composições farmacêuticas | |
CR7971A (es) | Sistema para monitoreo de paciente y suministro de farmaco y metodo de uso | |
DE59811404D1 (de) | Medizinisches Gerät, insbesondere zur Senkung des Augeninnendrucks | |
NO20034149D0 (no) | Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel | |
ATE415817T1 (de) | Agrochemische formulierungen | |
NO20064521L (no) | Framgangsmate og blanding for behandling av rhinitt | |
CY1107451T1 (el) | Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου | |
HN2004000109A (es) | Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso | |
BR0210489A (pt) | Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente | |
ITBO20000453A0 (it) | Apparecchiatura e procedimento per la sterilizzazione del terreno . | |
BRPI0516464B8 (pt) | método para a preparação de um produto farmacêutico | |
ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
DOP2002000457A (es) | Tetrahidroquinolinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |